Fil LTD Abiomed Inc Transaction History

Fil LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$262.71 - $351.17 $525 - $702	-2 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$251.88 - $324.2 $3,778 - $4,863	-15 Reduced 88.24%	2 $1,000
Q2 2020 Aug 13, 2020	BUY	$141.4 - $257.09 $282 - $514	2 Added 13.33%	17 $4,000
Q3 2019 Nov 13, 2019	SELL	$175.89 - $279.23 $175 - $279	-1 Reduced 6.25%	15 $3,000
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $12.4 Million - $14.1 Million	-49,574 Reduced 99.97%	16 $4,000
Q1 2019 May 13, 2019	BUY	$276.39 - $362.25 $1.66 Million - $2.17 Million	6,004 Added 13.78%	49,590 $14.2 Million
Q4 2018 Feb 13, 2019	SELL	$281.08 - $444.25 $5 Million - $7.91 Million	-17,798 Reduced 28.99%	43,586 $14.2 Million
Q3 2018 Nov 09, 2018	SELL	$354.53 - $449.75 $3 Million - $3.8 Million	-8,454 Reduced 12.11%	61,384 $27.6 Million
Q2 2018 Aug 10, 2018	SELL	$278.07 - $446.21 $6.78 Million - $10.9 Million	-24,379 Reduced 25.88%	69,838 $28.6 Million
Q1 2018 May 14, 2018	BUY	$192.49 - $295.85 $18.1 Million - $27.9 Million	94,217 New	94,217 $27.4 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.